GlaxoSmithKline Pharmaceuticals has reported results for the first quarter ended March 31, 2013
On standalone basis, the company has posted a rise of 37.53% in its net profit at Rs 169.01 crore for the quarter ended March 31, 2013 as compared to Rs 122.89 crore for the same quarter in the previous year. Total income of the company has increased marginally by 1.51% at Rs 713.84 crore for quarter under review as compared to Rs 703.19 crore for the quarter ended March 31, 2012.
GlaxoSmithKline Pharmaceuticals is one oldest pharmaceutical company in India. Internationally it has created many brands such as Ribena, Horlicks, Lucozade, Aquafresh, Sensodyne, Panadol, Tums and Zovirax, among others. It employs 5,000 people and has turnover of more than $1 billion in India.
